http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114032219-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d927148c7982a59521f5c2ed8ae37c0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-15006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0081
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_034092900f66477c538d7a67e88f06ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b9daa5fbf6fa0f9959beb1fce16536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090c4618852be7839aa928e241d60f48
publicationDate 2022-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114032219-A
titleOfInvention CYP4F22 Gene Mutants, Peptides, Kits, Constructs and Recombinant Cells
abstract The invention belongs to the technical field of biological genetic engineering, and discloses a CYP4F22 gene mutant, a polypeptide, a kit, a construct and a recombinant cell. The nucleic acid encoding the CYP4F22 mutant is the 844th nucleotide of the No. 8 exon, There is a C→T mutation, or the 1189th nucleotide of exon 11, there is a C→T mutation; the polypeptide has p.R282W or p.R397C mutation; the kit contains specific detection of CYP4F22 gene mutant p A reagent for R282W or p.R397C; the nucleic acid construct contains a CYP4F22 gene p.R282W or p.R397C mutant; the recombinant cells are obtained by transfecting recipient cells with the nucleic acid construct. The invention can be used for auxiliary diagnosis of congenital ichthyosis, for finding potential carriers of congenital ichthyosis, and providing basis for prenatal genetic diagnosis of the disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115856296-A
priorityDate 2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021046131-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID72054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493484
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID126410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407064580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID534967
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4051
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100063353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444732
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID290623
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100037390

Total number of triples: 37.